Last Price$20.72.1%
Market Cap$972.8M
17.1x
Industry median - 4.4x
5Y Historical average - 18.3x
4.3x
Industry median - 1.0x
5Y Historical average - 3.4x
FCF to Interest
(40.5x)
Industry median - (29.0x)
5Y Historical average - (89.7x)
0.0%
Industry median - 3.8%
5Y Historical average - 0.5%
ELVN Health Rating
ELVN Health rating
5.8
ELVN Health rating performance
ELVN Financial Stability & Strength
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
FCF to Interest
Intangibles as % of Total Assets
Competing with ELVN Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$972.8M | ($291.7M) | 5.8 | 17.4x | 17.1x | 4.3x | (40.5x) | 0.0% | 0.0% | |
$124.8B | ($4,366.4M) | 5.8 | 2.7x | 2.2x | 5.5x | (25.8x) | 3.7% | 10.7% | |
$77.0B | ($15.9B) | 6.6 | 33.5x | 29.7x | (4.4x) | 65.2x | 3.0% | 5.7% | |
$34.4B | N/A | 5.6 | N/A | N/A | N/A | (103.5x) | N/A | N/A | |
$30.7B | ($1,398.5M) | 6.9 | 2.8x | 2.6x | 32.8x | (0.3x) | 0.0% | 1,931.9% | |
$24.0B | (€16.5B) | 6.8 | 7.5x | 7.3x | 71.9x | (11.5x) | 3.5% | 1.3% | |
$14.5B | $5,841.4M | 4.7 | 1.4x | 1.4x | 2.1x | 12.3x | 0.0% | 73.6% | |
$13.8B | ($2,967.0M) | 6.9 | 5.2x | 4.8x | (2.7x) | 25.2x | 1.1% | 4.7% | |
$13.4B | ($535.0M) | 6.1 | 5.3x | 3.0x | (1.1x) | 38.5x | 3.7% | 10.7% | |
$13.3B | ($405.1M) | 6.8 | 10.2x | 9.9x | 2.9x | (16.4x) | 0.0% | 1.9% | |
$1,846.9M | ($1,600.5M) | 4.3 | 1.9x | 1.6x | 1.5x | N/A | 0.9% | 32.1% |
FAQ
What is the Enliven Therapeutics, Inc. (ELVN) quick ratio?
The Enliven Therapeutics, Inc. (ELVN) quick ratio is 17.1x, compared to the industry median of 4.4x and the 5-year historical average of 18.3x.
What is the Enliven Therapeutics, Inc. (ELVN) net debt to Free Cash Flow (FCF) ratio?
The Enliven Therapeutics, Inc. (ELVN) net debt to FCF ratio is 4.3x, compared to the industry median of 1.0x and the 5-year historical average of (3.4x).
What is Enliven Therapeutics, Inc. (ELVN) Free Cash Flow (FCF) to interest ratio?
Enliven Therapeutics, Inc. (ELVN) FCF to interest ratio is (40.5x), compared to the industry median of (29.0x) and the 5-year historical average of (89.7x).
What is the Enliven Therapeutics, Inc. (ELVN) total debt to equity ratio?
The Enliven Therapeutics, Inc. (ELVN) total debt to equity ratio is 0.0%, compared to the industry median of 3.8% and the 5-year historical average of 0.5%.